Moncef Slaoui

Type: Person
Name: Moncef Slaoui
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

New Role Created At GlaxoSmithKline's Vaccines Unit

The British pharmaceutical giant GlaxoSmithKline has announced it has appointed Dr Moncef Slaoui, one of the most influential figures in the industry, as the new chairman of vaccines.GSK, the largest drug manufacturer in the UK, says it is working to ... [Published BioSpace - Oct 23 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 8 reports

GSK taps Slaoui to chair flat-selling vaccines unit with an eye to the future

GlaxoSmithKline's ($GSK) vaccines unit will be getting a new look come next year, when it's expected to absorb the bulk of Novartis' ($NVS) vaccines lineup it bought for $7.1 billion back in April. It'll have some new management, too, with Moncef Slaoui ... [Published FierceVaccines - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Dr Moncef Slaoui: Is This The Man Who Can Save the World from Ebola?

The British pharmaceutical giant GlaxoSmithKline has announced it has appointed Dr Moncef Slaoui, one of the most influential figures in the industry, as the new chairman of vaccines. ... [Published Yahoo! News UK and Ireland - Oct 23 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund

GSK today announced a $5 million Innovation Challenge Fund (ICF) to further encourage and advance collaborative re as part of its effort to develop bioelectronic medicines. The fund will support academic groups and small companies who want to develop ... [Published Noodls - Oct 21 2014]
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

GSK creates $5 million Innovation Challenge Fund

A $5 million Innovation Challenge Fund (ICF), to encourage and support academic groups and small companies in collaborative efforts in the development of bioelectronic medicines, has been announced by GSK. This funding programme is in addition to the ... [Published Labmate Online - Oct 17 2014]
First reported Oct 10 2014 - Updated Oct 10 2014 - 1 reports

The Crowd: Celebrating champions of disease prevention

Here are some sobering facts. Despite all of the advances in science and medicine, more than 7,000 types of rare diseases affect the human condition.These rare diseases affect some 30 million Americans and, worldwide, an estimated 350 million people. ... [Published Daily Pilot - Oct 10 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 3 reports

Fast-tracking an Ebola vaccine

pBattling Ebola/p pCNBC's Meg Tirrell, and Dr. Moncef Slaoui, GlaxoSmithKline, discuss the latest efforts to develop an Ebola vaccine. pharmaceutical giant, said Tuesday on CNBC. "Normally, we need data from thousands, if not tens of thousands of healthy ... [Published Austin American Statesman - Oct 07 2014]
First reported Oct 04 2014 - Updated Oct 04 2014 - 1 reports

GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund

The FINANCIAL -- GSK announced a $5 million Innovation Challenge Fund (ICF) to further encourage and advance collaborative research as part of its effort to develop bioelectronic medicines. The fund will support academic groups and small companies who ... [Published Finchannel.com - Oct 04 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

GlaxoSmithKline : GSK appoints Mr Urs Rohner to its Board as a Non-Executive Director

Issued: London UKGlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015. On appointment, Mr Rohner will also become a member of GSK's Remuneration Committee.Mr ... [Published 4 Traders - Oct 03 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

GlaxoSmithKline to provide funding for bioelectronic medicine research

:13 in Pharmaceutical Company Product News GlaxoSmithKline has announced a new fund that will help to support academic groups and small companies in their efforts to develop bioelectronic medicines. The $5 million (3.1 million pounds) Innovation Challenge ... [Published Zenopa - Oct 02 2014]
First reported Sep 30 2014 - Updated Oct 01 2014 - 2 reports

GSK expands bioelectronics efforts with $5m challenge fund

GlaxoSmithKline (GSK) is setting up a $5m fund for external researchers working in the area of bioelectronic medicines, boosting its investment in the emerging technology.Earlier this year, GSK announced a prize of $1m for the first group to solve the ... [Published PMLive - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

GlaxoSmithKline deepens its commitment to 'electroceuticals'

GlaxoSmithKline ( $GSK ) is expanding its efforts to encourage research into bioelectronic medicine, putting up $5 million to support R&D projects around the world. GSK's latest ante follows a $1 million award unveiled last year, part of the company's ... [Published FierceBiotech - Sep 30 2014]

Quotes

...we need data from thousands, if not tens of thousands of healthy volunteers before we can make a vaccine available," Slaoui told CNBC this week. "in this particular setting ... we will need data from perhaps several hundred, maybe a thousand volunteers."
...world-leading engineers, physiologists, neuroscientists and informatics experts," said Moncef Slaoui, Chairman of Global R&D and Vaccines at GSK. "through this fund we're announcing today and the $1 million innovation challenge, we hope to address a critical need for that re community. the technology we target will unlock the next re phase towards a new class of treatments for patients."

More Content

All (30) | News (27) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
New Role Created At GlaxoSmithKline's Vaccines ... [Published BioSpace - Oct 23 2014]
Dr Moncef Slaoui: Is This The Man Who Can Save ... [Published Yahoo! News UK and Ireland - Oct 23 2014]
GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 ... [Published Seeking Alpha - Oct 23 2014]
GSK taps Slaoui to chair flat-selling vaccines ... [Published FierceVaccines - Oct 23 2014]
GSK Profit Falls; Plans Partial IPO Of ViiV Bus... [Published RTTNews.com - Oct 22 2014]
GSK to restructure as respiratory sales slump [Published MedNous - Oct 22 2014]
Dr Moncef Slaoui: Is This The Man Who Can Save ... [Published International Business Times UK - Oct 22 2014]
GSK dealmaking spawns management shake-up, putt... [Published FiercePharma - Oct 22 2014]
Ebola Outbreak: GlaxoSmithKline Claims It'll Be... [Published International Business Times UK - Oct 22 2014]
Glaxo Holds Full Year Expectations, But Launche... [Published 4 Traders - Oct 22 2014]
GlaxoSmithKline PLC : Re Directorate [Published Investegate - Oct 22 2014]
BRIEF-Glaxosmithkline names Moncef Slaoui as Ch... [Published Reuters UK - Oct 22 2014]
GSK commits further funding to advance bioelect... [Published Noodls - Oct 21 2014]
GSK creates $5 million Innovation Challenge Fund [Published Labmate Online - Oct 17 2014]
The Crowd: Celebrating champions of disease pre... [Published Daily Pilot - Oct 10 2014]
Fast-tracking an Ebola vaccine [Published Austin American Statesman - Oct 07 2014]
Fast-tracking an Ebola vaccine may prove too slow [Published CNBC - Oct 07 2014]
Video: Battling Ebola [Published NBCNews.com - Oct 07 2014]
GSK commits further funding to advance bioelect... [Published Finchannel.com - Oct 04 2014]
GlaxoSmithKline : GSK appoints Mr Urs Rohner to... [Published 4 Traders - Oct 03 2014]
GlaxoSmithKline to provide funding for bioelect... [Published Zenopa - Oct 02 2014]
Therapeutic Focus 2014: Vaccines [Published Medical Marketing And Media - Oct 01 2014]
GSK expands bioelectronics efforts with $5m cha... [Published PMLive - Oct 01 2014]
GlaxoSmithKline deepens its commitment to 'elec... [Published FierceBiotech - Sep 30 2014]
GSK commits $5M to startups, academics that dev... [Published MedCity News - Sep 30 2014]
Ebola vaccine to be tested on British volunteer... [Published Telegraph - Aug 28 2014]
Tiny implantable devices the future of medicine? [Published FOX Business - Video - Jun 11 2014]
[tt] NYT: Michael Behar: Can the Nervous System... [Published TranshumanTech - May 27 2014]
Hanging Out in Hollywood with People who “Get T... [Published theCSRfeed - May 05 2014]
A Spark From GSK [Published Pharmaceutical Executive - Feb 05 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Tiny implantable devices the future of medicine? [Published FOX Business - Video - Jun 11 2014]
GlaxoSmithKline Global R&D chairman Moncef Slaoui on the development of bioelectronic medicines. ...
[tt] NYT: Michael Behar: Can the Nervous System... [Published TranshumanTech - May 27 2014]
Michael Behar: Can the Nervous System Be Hacked? http://www.nytimes.com/2014/05/25/magazine/can-the-nervous-system-be-hacked.html Michael Behar writes about science and the environment. His work hasappeared in "The Best American Travel Writing" and "The ...
Hanging Out in Hollywood with People who “Get T... [Published theCSRfeed - May 05 2014]
SOURCE: GlaxoSmithKline DESCRIPTION: You might be able to spot a Hollywood star or two this week at the Beverly (Hills) Hilton Hotel, but the normal red carpet crowd is being replaced by an eclectic group of leaders to discuss important issues ranging ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.